HOME >> BIOLOGY >> NEWS
JCI table of contents, March 9, 2006

, which develops human-like asthma symptoms including airway hyperresponsiveness (AHR), mucus production, production of proinflammatory proteins called cytokines, and increased numbers of immune cells called eosinophils and Th2 cells in the lung. The researchers injected these asthmatic mice with an antibody that stimulates the activity of an immune protein called CD137. A single injection of this "agonistic" anti-CD137 antibody was able to inhibit AHR, eosinophilic airway inflammation, and Th2 cytokine production for the complete observation period of almost 7 weeks. The lasting effects of this treatment suggest that this type of antibody therapy may be used in the future to treat the recurring symptoms of allergy in humans. Specifically, the authors suggest that strategies aimed at stimulation of CD137, which has previously been shown to induce tumor rejection, may represent a clinical target for allergic inflammatory responses and other disorders characterized by inappropriate T cell activation.

TITLE: CD137-mediated immunotherapy for allergic asthma

AUTHOR CONTACT: Gesine Hansen
Medizinische Hochschule
Hannover, Hannover, Germany
Phone: 0049-511-532-9138; Fax: 0049-511-532-9125; E-mail: hansen.gesine@mh-hannover.de
View the PDF of this article at: https://www.the-jci.org/article.php?id=23792


'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
9-Mar-2006


Page: 1 2 3 4 5 6

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... ... ... Mount Sinai researchers have discovered how the enzyme DNA polymerase delta works to ... a study published in Nature Structural & Molecular Biology, the team also reported how ... diseases. , “DNA polymerase delta serves as the duplicating machine for the millions to ...
(Date:9/30/2019)... ... September 30, 2019 , ... USDM Life Sciences ... life science organizations to accelerate innovation and maximize productivity, announces that David Blewitt ... What: Just 30 days to 21 CFR Part 11 compliance with Box, When: ...
(Date:9/25/2019)... ... September 25, 2019 , ... Modality Solutions, a ... on Inc. Magazine’s annual Inc. 5000 list, the most prestigious ranking of the ... Based on this growth, the Houston-based firm also ranked No. 47 in its ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), ... clinical trial sites and physician investigators. The clinical trial sites are now ... Clinical trial sites are currently located in San Diego and Los Angeles California, ...
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was ... months old, Tucker was limping and lame on his right hip and elbow. At ... it was called “the worst case the vet had seen.” He was prescribed pain ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global Healthcare Innovation ... Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO Innovation Center ... a careful process of evaluation, twelve companies out of over 200 applications were ...
Breaking Biology Technology:
Cached News: